Suggestion of CR is crazy?, page-3

I've taken a quote from the 'DTZ Charting and TA thread' and replying here to keep the other thread for specifically for charting and TA only.

I'm having difficulty understanding why you think now wouldn't be a good time to invest in DTZ.
As you stated; DTZ has $2.8m cash in bank and an estimated cash burn next quarter of $800k, which comfortably provides 3 quarters (~9 months) of cash.

Now for a company that is already ahead of schedule and has had the following announcements post-listing (~4 months):
15/11/16 - Establishes $20Mil Research centre with NTU Singapore
22/11/16 - Dotz Nano Achieves 65% Quantum Yield
8/12/16 - Expands Production Capability
19/12/16 - Awarded conditional $1.2mil commercial grant
9/1/17 - Signs Marketing & sales agreement with strem chemicals
25/1/17 - Signs Distribution agreement with Mainami holdings
30/1/17 - Dispatches First shipment of Graphene quantum dots
31/1/17 - An excellent FAQ for holders
10/2/17 - Dotz Nano Limited completes Proof of Concept research with Kyung Hee University to use GQDs in Flash Memory
17/2/17 - Dotz Nano continues commercialisation of GQDs and dispatches first shipment to China
17/2/17 - Commercial discussions update.

Would you really want to miss out on future announcements like these?

I'd especially like to point of these beauty's from the announcements:
1. "The Company secured additional production capacity for GQDS from 50kgs up to 100kgs per annum in anticipation of sales pipeline over the coming months”.
2. "This is the first commercial shipment into the Chinese market and will update further sales".
3. Dotz Nano Limited is in advanced negotiations for a comprehensive research agreement with Kyung Hee University and optional exclusive Licensing Rights for the development and commercialisation of GQD Flash Memory devices.

Management have yet to step wrong in running DTZ and have ample hints of negotiations with many companies (Merck and Henkel) and future commercial sales of their GQDs. They have also been applying for many grants (recently success of $1.2m from the BIRD Foundation) to alleviate any intentions of a CR.

One of my concerns with DTZ was where they would get the financing from for their NTU research centre.
DTZ and NTU Singapore will provide up to ~$18 million AUD in joint funding over a 5 year period. In addition to the above financing, both parties will endeavour to obtain additional grant funding from other sources. The funding will be each party contributing ~9 million AUD where half would be in cash over a 5 year period and the other half in kind (salaries, use of research equipment etc.).
That’s just S$2 million a year which we expect to be funded purely from our revenues as the commercialisation process rolls out.

I'm not saying there won't be a CR in the future - CR's are obviously essential for companies to expand and grow which is very important for a future monopolistic high quality producer like DTZ. However, the discount price of when the CR occurs could be a hell of a lot higher than what you can get in now IMO.

Open/happy to hear criticism!